CLEO Diagnostics kicks off ovarian cancer-detecting blood test trials in USA
CLEO Diagnostics (ASX:COV) has revealed it’s kicked off US-based trials sussing the…
Cleo Diagnostics Ltd (ASX:COV)
About Cleo Diagnostics Ltd
Key Information
COV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 16/10/2024 | Price Sensitive PS Quarterly activities and cashflow report | 711.6KB | 3.4K |
| 04/10/2024 | Letter to Shareholders | 2.18MB | 491 |
| 04/10/2024 | Notice of Annual General Meeting/Proxy Form | 731.29KB | 218 |
| 23/09/2024 | Notice Required Under ASX Listing Rule 3.13.1 | 310.63KB | 262 |
| 06/09/2024 | Price Sensitive PS Cleo Commences U.S. Clinical Trials | 526.04KB | 3.6K |
| 28/08/2024 | ASX Listing Rule 4.10.19 | 348.64KB | 294 |
| 27/08/2024 | Appendix 4G and Corporate Governance Statement | 445.04KB | 254 |
| 27/08/2024 | Price Sensitive PS Appendix 4E and 2024 Annual Report | 6.18MB | 424 |